Australia markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6582+0.0302 (+4.81%)
At close: 04:00PM EDT
0.6690 +0.01 (+1.64%)
After hours: 07:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.49M
Enterprise value 4.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.06
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.48

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-36.73%
S&P500 52-week change 322.36%
52-week high 31.7500
52-week low 30.2740
50-day moving average 30.7587
200-day moving average 30.5675

Share statistics

Avg vol (3-month) 35.41M
Avg vol (10-day) 378.71k
Shares outstanding 517.45M
Implied shares outstanding 618.28M
Float 88.31M
% held by insiders 152.35%
% held by institutions 11.55%
Shares short (15 Apr 2024) 4150.01k
Short ratio (15 Apr 2024) 40.6
Short % of float (15 Apr 2024) 42.92%
Short % of shares outstanding (15 Apr 2024) 40.86%
Shares short (prior month 15 Mar 2024) 4229.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-53.66%
Return on equity (ttm)-107.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-8.4M
Diluted EPS (ttm)-0.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.27M
Total cash per share (mrq)0.42
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.17
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-7.86M
Levered free cash flow (ttm)-5.01M